Archives

by in
Entry Author Date Location
San Diego Life Sciences Roundup: Optimer, Ambit, AnaptysBio, & More 05/17/13 San Diego
Boston Biotech Seizes the Momentum: Last Chance for Early Bird Tix 03/07/13 Boston
Someone Needs to Rank U.S. Biotech Hubs, For Real 03/04/13 National
RNA Therapeutics Are Coming of Age 02/08/13 San Diego
Who Are Biotech’s New Go-To Investment Bankers? 11/12/12 National
The Hepatitis C Market: Biotech’s Version of the Daytona 500 12/12/11 National
The Fall of Pfizer: How Big is Too Big for Pharma Innovation? 08/29/11 National
Regulus, the MicroRNA Child of Alnylam and Isis, Offers Litmus Test for Biotech Hope in 2011 02/07/11 San Diego
Top Trends to Watch in 2011 From Experts in Infotech, Biotech, Cleantech 01/19/11 National
John Mendlein Tries His Hand as a ‘Parallel Entrepreneur,’ Santaris Continues RNA Therapeutics Work for Pfizer, & More San Diego Life Sciences News 01/06/11 San Diego
Regulus Therapeutics, Spinoff of Isis and Alnylam, Forms $750M MicroRNA Deal With Sanofi 06/22/10 San Diego
Regulus, the MicroRNA Child of Isis and Alnylam, Strikes Potential $150M Deal with Glaxo 02/25/10 San Diego
Merck’s Alan Sachs, on RNAi’s Big Challenge: Delivery, Delivery, Delivery 01/21/10 National
Xconomy Forum: The Biotech Odyssey and Xconomy’s Ode to Innovation and Clean Air 12/15/09 San Diego
Nobel Laureate from Caltech, RNAi Leader To Headline Xconomy San Diego Event on Monday 12/09/09 San Diego
San Diego Biotech Leaders on the Future of Stem Cells, MicroRNA, & Cancer Biology 12/01/09 San Diego
Alnylam and Isis’ Offspring, Regulus, Keeps Pushing on Biology’s ‘Bleeding Edge’ 07/28/09 San Diego
Regulus Therapeutics Follows Through on Fundraising, Independence Plans 03/04/09 San Diego
Alnylam Looks to Spinoffs To Unleash RNAi Technologies for Stem Cells, Vaccines 02/18/09 Boston
Pfizer-Wyeth Combo’s Impact on San Diego Biotech: Bad for Dealmaking, Good for Shareholders 01/27/09 San Diego
Regulus, Leading Developer of MicroRNA Drugs, Prepares to Get Independence from Alnylam and Isis 01/21/09 San Diego
MicroRNA Leaps Ahead: Alnylam-Isis Venture, Regulus, Shows Its Drug Works in Animals With Heart Failure 11/30/08 San Diego
Sirtris Shifts Focus From Resveratrol, Merck Shifts People From Seattle to Boston, Epix Shifts Into Cost-Saving Mode, & More Boston-Area Life Sciences News 10/29/08 Boston
Page 1 of 1

Xconomy Events Across the Network

The Napa Summit 2013: New Rules for Growth

San Francisco · 6/3/13

More Xconomy Events

Xconomy’s Most Popular

  1. Nine Lessons for Innovators from a Nobel Prize-Winning Psychologist
  2. Henri Termeer on Startups, Drug Prices, Getting Older (Part 1)
  3. Xconomy Opens in Texas, Expanding Roundup of Innovation Across U.S.
  4. Zillions of Biotech Conferences Want You. Which Should You Attend?
  5. Announcing Xconomy Napa Summit 2013: New Rules for Growth

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.